Sony focuses on advancing genetic research in Japan

Search giant Google last year formed a company focused on tackling aging and other associated diseases, and now Sony is upping its commitment to breakthrough medicine after it announced a joint venture focused on advancing medical research using genetics in Japan. 

Sony is forming a new company to focus on genome research with a view towards realizing personalized medicine and healthcare. The venture, currently called P5 Inc, is a collaboration with M3, a medical company in which Sony is the majority stakeholder, and Illumina, a US-based manufacturer of genome-sequencing equipment. News of the tie-up between Sony and Illumina, which will be a minority investor, was first reported by Jiji Press last year. Sony refers to the collaboration as a “genome information platform.” It will provide genome analysis services for enterprises and research institutions in Japan at first, as well as aggregating genetic data with other medical data.

By Jesseb Shiloh

+Jesseb Shiloh is new to blogging. He enjoys things that most don't and dismisses society as an unfortunate distraction. Find him on WeHeartWorld, Twitter, Facebook, and Pinterest.

Leave a comment

Your email address will not be published. Required fields are marked *